Formic Acid

Formic Acid

SCHEMBL30493146

Nc1nncc2ccccc12.O=CO

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ GOT1 P17174 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MPO P05164 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ THPO P40225 1/20 0.47
▸ AOX1 Q06278 1/20 0.47
▸ ACOX1 Q15067 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL600018 0.89 KDM4E (0.57) KDM4ELMNATP53CYP3A4GOT1
SCHEMBL29560277 0.89 KDM4E (0.57) KDM4ELMNATP53CYP3A4GOT1
Hydrochloric Acid SCHEMBL27687770 0.87 KDM4E (0.58) KDM4ELMNATP53CYP3A4GOT1
Trifluoroacetic Acid SCHEMBL29015415 0.80 C1S (0.62) KDM4ELMNATP53CYP3A4GOT1
Formic Acid SCHEMBL30214020 0.79 ERN1 (0.41) KDM4ELMNACYP3A4ALDH1A1CYP1A2
Formic Acid SCHEMBL30994748 0.79 ERN1 (0.38) KDM4ELMNACYP3A4ALDH1A1CYP1A2
Chlorobenzene SCHEMBL27514649 0.79 KDM4E (0.47) KDM4ELMNATP53CYP3A4GOT1
Formic Acid SCHEMBL30738145 0.73 F12 (0.78) LMNACYP3A4SMN1; SMN2NPC1RAB9A
SCHEMBL224748 0.72 NPC1 (0.47) KDM4ELMNATP53CYP3A4GOT1
Formic Acid SCHEMBL30452445 0.71 LCK (0.41) KDM4ELMNATP53SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12304915-B2 SOS1 inhibitors Mirati Therapeutics, Inc. (US) 2025-05-20 — — US disclosed
US-20250059182-A1 SOS1 INHIBITORS MIRATI THERAPEUTICS, INC 2025-02-20 — — US disclosed
US-20230137886-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12304915-B2 SOS1 inhibitors SOS1, SOS2, SAV1 KDM4E 3245/4885LMNA 3751/4885TP53 194/4885
US-20250059182-A1 SOS1 INHIBITORS SOS1, SOS2, SOST KDM4E 2892/4885LMNA 3902/4885TP53 447/4885
US-20230137886-A1 SOS1 INHIBITORS SOS1, SOS2, SAV1 KDM4E 3245/4885LMNA 3751/4885TP53 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback